Jianjun Cao

Jianjun Cao

Auto-generated profile, based on publicly available information

Jianjun Cao

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2022 in Science
Verified
Journal Article
Closed access
JCJianjun Cao
Jianjun Cao
MBMatthew J. Belousoff
Matthew J. Belousoff
YLYi-Lynn Liang
Yi-Lynn Liang
RJRachel M. Johnson
Rachel M. Johnson
TJTracy Josephs
Tracy Josephs
PSPatrick M Sexton
Patrick M Sexton
Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity–modifying proteins (RAMPs), AMY 1 R, AMY 2 R, and AMY 3 R. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMY 1 R with salmon CT (sCT), AMY 2 R with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.

9 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
TJTracy Josephs
Tracy Josephs
MBMatthew J. Belousoff
Matthew J. Belousoff
YLYi-Lynn Liang
Yi-Lynn Liang
SPSarah Piper
Sarah Piper
JCJianjun Cao
Jianjun Cao
PSPatrick M Sexton
Patrick M Sexton
Dynamic activation of a GPCR: G protein–coupled receptors (GPCRs) coordinate a complex information flow between the outside and inside of a cell. An increasing number of GPCR structures provide insight into function. However, the dynamics that link extracellular sensing to intracellular signaling are not completely understood, because GPCRs used in structure determination are generally modified to constrain their dynamics. Josephs et al. succeeded in determining the structures of an unmodified calcitonin gene–related peptide receptor, which is implicated in migraines, both alone and bound to its neuropeptide ligand. Based on the structures and data from complementary biophysical techniques, they show that initial binding of the peptide causes only minor conformational changes of the GPCR, but dynamically causes changes at the intracellular side that facilitate G protein binding and activation. Science , this issue p. eabf7258

3 August 2023 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
JCJianjun Cao
Jianjun Cao
MBMatthew J. Belousoff
Matthew J. Belousoff
EGElliot Gerrard
Elliot Gerrard
RDRadostin Danev
Radostin Danev
MFMadeleine M. Fletcher
Madeleine M. Fletcher
PSPatrick M Sexton
Patrick M Sexton

21 May 2026 in Nature
Verified
Journal Article
Closed access
EMEdin Muratspahić
Edin Muratspahić
DFDavid Feldman
David Feldman
DKDavid E. Kim
David E. Kim
XQXiangli Qu
Xiangli Qu
ABAna-Maria Bratovianu
Ana-Maria Bratovianu
DBDavid Baker
David Baker

10 April 2025 in Nature Communications
Verified
Journal Article
Open access
JCJianjun Cao
Jianjun Cao
MBMatthew J. Belousoff
Matthew J. Belousoff
RJRachel M. Johnson
Rachel M. Johnson
PKPeter Keov
Peter Keov
ZMZamara Mariam
Zamara Mariam
PSPatrick M Sexton
Patrick M Sexton
Obesity is a major and increasingly prevalent chronic metabolic disease with numerous comorbidities. While recent incretin-based therapies have provided pharmaceutical inroads into treatment of obesity, there remains an ongoing need for additional medicines with distinct modes of action as independent or complementary therapeutics. Among the most promising candidates, supported by phase 1 and 2 clinical trials, is cagrilintide, a long-acting amylin and calcitonin receptor agonist. As such, understanding how cagrilintide functionally engages target receptors is critical for future development of this target class. Here, we determine structures of cagrilintide bound to Gs-coupled, active, amylin receptors (AMY1R, AMY2R, AMY3R) and calcitonin receptor (CTR) and compare cagrilintide interactions and the dynamics of receptor complexes with previously reported structures of receptors bound to rat amylin, salmon calcitonin or recently developed amylin-based peptides. These data reveal that cagrilintide has an amylin-like binding mode but, compared to other peptides, induces distinct conformational dynamics at calcitonin-family receptors that could contribute to its clinical efficacy.

11 April 2024 in Biochemistry
Verified
Journal Article
Open access
JCJianjun Cao
Jianjun Cao
MBMatthew J. Belousoff
Matthew J. Belousoff
RDRadostin Danev
Radostin Danev
ACArthur Christopoulos
Arthur Christopoulos
DWDenise Wootten
Denise Wootten
PSPatrick M Sexton
Patrick M Sexton
Inhibition of calcitonin gene-related peptide (CGRP) or its cognate CGRP receptor (CGRPR) has arisen as a major breakthrough in the treatment of migraine. However, a second CGRP-responsive receptor exists, the amylin (Amy) 1 receptor (AMY1R), yet its involvement in the pathology of migraine is poorly understood. AMY1R and CGRPR are heterodimers consisting of receptor activity-modifying protein 1 (RAMP1) with the calcitonin receptor (CTR) and the calcitonin receptor-like receptor (CLR), respectively. Here, we present the structure of AMY1R in complex with CGRP and Gs protein and compare it with the reported structures of the AMY1R complex with rat amylin (rAmy) and the CGRPR in complex with CGRP. Despite similar protein backbones observed within the receptors and the N- and C-termini of the two peptides bound to the AMY1R complexes, they have distinct organization in the peptide midregions (the bypass motif) that is correlated with differences in the dynamics of the respective receptor extracellular domains. Moreover, divergent conformations of extracellular loop (ECL) 3, intracellular loop (ICL) 2, and ICL3 within the CTR and CLR protomers are evident when comparing the CGRP bound to the CGRPR and AMY1R, which influences the binding mode of CGRP. However, the conserved interactions made by the C-terminus of CGRP to the CGRPR and AMY1R are likely to account for cross-reactivity of nonpeptide CGRPR antagonists observed at AMY1R, which also extends to other clinically used CGRPR blockers, including antibodies.